Literature DB >> 22798974

An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Magalys Vitiello, Adriana Abuchar, Néstor Santana, Luis Dehesa, Francisco A Kerdel.   

Abstract

Systemic sclerosis is a connective tissue disorder that affects multiple organs. Although the initial symptoms of the disease are vascular, skin involvement is almost universally present in patients with systemic sclerosis. The presence of Raynaud's phenomenon, progressive thickening of the skin, digital ulcers, and calcinosis all correlate proportionally with disease severity. Since no treatment is available to completely prevent the natural course of the disease, emphasis is often placed on managing symptoms and complications. In this review, the authors focus on the management of each one of the skin manifestations seen in systemic sclerosis, as the dermatologist may facilitate the early recognition and treatment of these complications.

Entities:  

Year:  2012        PMID: 22798974      PMCID: PMC3396456     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  104 in total

1.  Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases.

Authors:  Zenshiro Tamaki; Yoshihide Asano; Masaru Hatano; Atsushi Yao; Tomohiko Kawashima; Manabu Tomita; Koichiro Kinugawa; Ryozo Nagai; Shinichi Sato
Journal:  Mod Rheumatol       Date:  2011-06-03       Impact factor: 3.023

2.  Relaxins: lessons and limitations.

Authors:  James R Seibold
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

3.  Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin--a preliminary report.

Authors:  Y Levy; Y Sherer; P Langevitz; M Lorber; P Rotman; F Fabrizzi; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

4.  Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy.

Authors:  Agnès Sparsa; Nicolas Lesaux; Emmanuel Kessler; Jean-Marie Bonnetblanc; Sophie Blaise; Valérie Lebrun-Ly; Pierre Colombeau; Elisabeth Vidal; Christophe Bédane
Journal:  J Am Acad Dermatol       Date:  2005-11       Impact factor: 11.527

5.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

6.  D-Penicillamine--induced pemphigus syndrome.

Authors:  C W Yung; G W Hambrick
Journal:  J Am Acad Dermatol       Date:  1982-03       Impact factor: 11.527

7.  Successful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser.

Authors:  Alexander J Chamberlain; Neil P J Walker
Journal:  Dermatol Surg       Date:  2003-09       Impact factor: 3.398

8.  Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients.

Authors:  P J Clements; P A Lachenbruch; M Sterz; G Danovitch; R Hawkins; A Ippoliti; H E Paulus
Journal:  Arthritis Rheum       Date:  1993-01

9.  Pentoxyphylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis.

Authors:  Romy Beatriz Christmann de Souza; André Regis Macedo; Kátia Akemi Kuruma; Patricia Andrade Macedo; Claudia Teresa Lobato Borges
Journal:  Clin Rheumatol       Date:  2009-05-26       Impact factor: 2.980

10.  Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.

Authors:  D E Furst; P J Clements; S Hillis; P A Lachenbruch; B L Miller; M G Sterz; H E Paulus
Journal:  Arthritis Rheum       Date:  1989-05
View more
  11 in total

1.  Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.

Authors:  Antonia Valenzuela; Lorinda Chung; Livia Casciola-Rosen; David Fiorentino
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

2.  High fluence light emitting diode-generated red light modulates characteristics associated with skin fibrosis.

Authors:  Andrew Mamalis; Eugene Koo; Manveer Garcha; William J Murphy; R Rivkah Isseroff; Jared Jagdeo
Journal:  J Biophotonics       Date:  2016-05-13       Impact factor: 3.207

3.  Digital ulcers in scleroderma patients: A retrospective observational study.

Authors:  A De Cata; M Inglese; F Molinaro; S De Cosmo; R Rubino; M Bernal; G Mazzoccoli
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

4.  Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.

Authors:  María Pilar Cruz-Domínguez; Grettel García-Collinot; Miguel A Saavedra; Gabriela Medina; Rosa Angélica Carranza-Muleiro; Olga Lidia Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2016-10-07       Impact factor: 2.980

5.  Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.

Authors:  Yasaman Motlaghzadeh; Laila S Tabatabai; Eric Longo; Deborah E Sellmeyer
Journal:  Osteoporos Int       Date:  2022-07-26       Impact factor: 5.071

Review 6.  Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review.

Authors:  Ana Elísabet López-Sundh; A Quintana-Sancho; C Durán-Vian; L Reguero-DelCura; A F Corrales-Martínez; C Gómez-Fernández; M A González-López
Journal:  Clin Rheumatol       Date:  2020-11-26       Impact factor: 2.980

7.  MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.

Authors:  Andrew Mamalis; Eugene Koo; Clifford Tepper; Jared Jagdeo
Journal:  J Biophotonics       Date:  2019-02-01       Impact factor: 3.207

Review 8.  Visible Red Light Emitting Diode Photobiomodulation for Skin Fibrosis: Key Molecular Pathways.

Authors:  Andrew Mamalis; Daniel Siegel; Jared Jagdeo
Journal:  Curr Dermatol Rep       Date:  2016-04-16

Review 9.  Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims Proposed Under European Community Regulation 1924/2006 in the Framework of Maintenance of Skin Function.

Authors:  Daniela Martini; Donato Angelino; Chiara Cortelazzi; Ivana Zavaroni; Giorgio Bedogni; Marilena Musci; Carlo Pruneti; Giovanni Passeri; Marco Ventura; Daniela Galli; Prisco Mirandola; Marco Vitale; Alessandra Dei Cas; Riccardo C Bonadonna; Sergio Di Nuzzo; Maria Beatrice De Felici; Daniele Del Rio
Journal:  Nutrients       Date:  2017-12-22       Impact factor: 5.717

10.  The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.

Authors:  A Mitropoulos; A Gumber; H Crank; M Akil; M Klonizakis
Journal:  Arthritis Res Ther       Date:  2018-06-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.